Close Icon We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Products:

Pharma Consulting

Conferences 2020

Awards

Upcoming Webinars

Webinar recordings

Close Icon

Global Search Configuration

Search Site Products & Services
Close Icon

Search by Keyword

Focus
Needs

Clinical trial Intelligence for contract research organizations

We help CROs win business and enhance drug development services. Make better-informed decisions while bidding on and implementing clinical trials.

The key to trial success

There are some trials that could be great for your business and others that might not be. But without high-quality intelligence, it can be hard to assess or maximize a trial’s potential.

How we help
Our thorough and extensive clinical trial intelligence for CROs will help your organization:

Identify clinical trials that may be completing, as well as company’s planned clinical trials
Make the right go/no-go decision
Design clinical trials that eliminate the need for additional trials, avoiding extra costs
Quickly identify and generate your short list of investigators

We’ll help you identify companies active in your territory and their phases of development. Spot where to run trials, with our data on where comparator trials have been approved and the availability of regional investigators.

You can size up competing trials, because we monitor and benchmark them, prioritizing investigators and tracking enrollment. And to help you mitigate risks, we can provide intelligence on safety issues faced by trials of similar designs.

Our unique strengths

Position your organization to win more business

Helping with everything from lead generation to targeting, proposal preparation to feasibility assessments and bid defenses, our intelligence will help you secure more successful trials.

Find trial-experienced investigators globally

Use the industry’s best source for checking investigator availability in regions, as well as prioritizing and targeting investigators with the right trial experience.

Set your trials up for approval

Shorten the timeline to protocol submission and approval with our clinical trials research and intelligence.

Make better informed decisions

Use our intelligence to inform the design of your clinical trials, bringing efficiencies to the process.

Benefit from a dedicated service

Our services come with dedicated client service and analyst support.

View more
View Less

Relevant products

Pharmaprojects: track pharma R&D

The industry’s most trusted drug development database, Citeline's Pharmaprojects has been covering pharma R&D across global markets for 35+ years. With 68,000+ drug profiles including 15,000 drugs in active development, it’s the go-to resource for preclinical, clinical, and pipeline coverage, and lifecycle management tracking.

Key benefits:

Curated by experts
Drug R&D landscape
Historical trends

Sitetrove: Clinical trial site & investigator identification

Over 450,000 investigators from 170,000+ sites in 180+ countries, all with clinical trial experience, at your fingertips. Support your trial success and inform your principal investigator (PI) and site selection activities with Sitetrove.

Key benefits:

Investigator Tiering
Patient Count Data
Dynamic/Exportable Visualizations

Trialtrove: gold standard clinical trials intelligence

Trialtrove is the go-to resource for clinical trial research. Easily track your competitors' clinical R&D activity with expert insights and continually monitored trials.

Key benefits:

Curated by experts
Clinical trial landscape view
Ask-the-Analyst™

View all content

Citeline

Clinical Trials & the COVID-19 Vaccine

Informa Pharma Intelligence’s Pulse Report

Topic Coronavirus Clinical Trials

Single report
Citeline

The New Normal for Clinical Trials and Planning for the Future Webinar

Join our panel of experts as they discuss the impact of COVID-19 on clinical trials, the new normal and future pathways to get ahead. Get the latest insights and status on recent clinical trials, the emergence of virtual trials, and what you need to know for success.

Topic Clinical Trials

Full webinar
Citeline

Rare Congenital and Genetic Diseases Strategy Solutions

Gain Clarity of Sight into What Comes Next with Citeline According to Informa’s Pharmaprojects, less than 3% of all rare congenital and genetic diseases have an approved therapy. Opportunities abound if you know the risks. Make better strategic and planning decisions with Intelligence services that give you a clear line of sight, helping you maximize clinical and commercial opportunities, navigate uncertainties, and ensure more successful outcomes.

Topic Diseases

View white paper
Citeline

The Future of Clinical Trials From the Investigator Perspective Webinar

Listen to our podcast “The Future of Clinical Trials From the Investigator Perspective” from earlier this year and register for our upcoming webinar to learn new developments

Topic Clinical Trials Coronavirus

View article
Citeline Engage

Citeline Engage: Recruit

A recent survey found 44% of investigators anticipate COVID-19 having a negative impact on their future ability to enroll patients in clinical trials. The adoption of virtual/decentralized trials on a larger, global scale will make the recruitment of patients more complex. To avoid the risk of failure, Citeline Engage can help you recruit experienced investigators with known patient pools and specialized physicians in proximity to support patient referrals.

Topic Clinical Trials

View case study
Pharmaprojects

Pharma RD Annual Review 2020 Whitepaper

Using the new, granular datapoints in Pharmaprojects, Senior Director Ian Lloyd presents his expert insights into pharma’s R&D activities over the past year and what they may mean for the pipeline during the year to come. The 27th instalment of the Annual Review, this version takes advantage of improvements to Pharmaprojects’ data granularity to bring you details on pharma R&D trends

Topic Drug Development Landscape Drug Review Research & Development

View white paper
Citeline, Biomedtracker, Pharma Consulting, Datamonitor Heal...

COVID-19 24 hour webinar recordings

Catch up on any missed COVID-19 24 hour webinar sessions

Topic Cardiovascular Coronavirus

Full video
Citeline

2019 Completed Trials: The Beat Goes On for Industry Sponsored Trial Activity

Get the big picture trends and key takeaways with Citeline’s infographic, 2019 Completed Trials: The Beat Goes on for Industry Sponsored Trial Activity. Using pivotal data from Sitetrove, Trialtrove and Pharmaprojects, our graphic analysis covers the major industry clinical developments as only Citeline can.

Topic Clinical Trials

View infographic
Citeline

2019 Completed Trials: The Beat Goes on for Industry Sponsored Trial Activity

Tap into expert analysis of the trends and what they mean for the future of pharma with Citeline’s latest whitepaper, 2019 Completed Trials: The Beat Goes on for Industry Sponsored Trial Activity.

Topic Clinical Trials

View white paper
Citeline, Datamonitor Healthcare

COVID-19 24-hour web event: Lessons learned and a path forward

This web event has now ended. You will be able to watch all sessions on demand soon. Register your interest now to receive an update when all sessions are available to view.

Topic Coronavirus

View interactive data
Citeline Engage

Citeline Engage: Clinical trial timeline

See how Citeline Engage can help you at every stage of your clinical trial

Topic Clinical Trials Clinical Trial Optimization

View infographic
Citeline

The “New Normal” for Clinical Research in the Wake of COVID-19

We conducted a survey to 100 clinical trial investigators to gauge expectations for future clinical research. Your free infographic provides key insight and analysis to help you understand the future clinical trial landscape.

Topic Coronavirus Clinical Trials

View infographic
Pharmaprojects

New Active Substances (NAS) Launched During 2019 Infographic

Don’t miss your view into the NAS that made an impact last year, your follow-up to the Pharma R&D Annual Review 2020 webinar.

Topic Clinical Trials Research & Development

View infographic
Pharmaprojects

Pharma R&D Annual Review 2020 Whitepaper - NAS Supplement

Recently, Pharma Intelligence brought you the Pharma R&D Annual Review 2020 Webinar, followed up with the NAS (New Active Substances) Infographic. We now invite you to go even deeper into pharma R&D successes for 2019 with your free copy of the NAS Supplement.

Topic Clinical Trials Research & Development

View white paper
Pharmaprojects

Pharma R&D Review 2020 Webinar

The pharma industry is moving into a new decade, and Pharmaprojects is here with insights into what we can expect in the year ahead. Join us to examine the trends and pipelines in a new level of granular detail. Get a taste of the direction R&D is heading in the Pharma R&D Annual Review Webinar.

Topic Clinical Trials Drug Development Landscape

Full video